Bioequivalence of huperzine A sustain-release tablets in healthy volunteer
Chunjie Sha
Abstract
Chunjie Sha
Abstract
Objective To study the bioavailability of the tested and reference huperzine A sustain-release tablets in healthy male volunteers.Methods According to the four-crossing design,each volunteer was orally given huperzine A sustain-release tablets or huperzine A.The plasma concentrations were determined by LC-MS/MS.Pharmacokinetic parameters were obtained using DAS 2.0 program.Results The main pharmacokinetic parameters of huperzine A tablets test and reference were as follows: Cmax were(0.75±0.25),(1.57±0.44)ng·mL-1,Tmax were(5.77±3.60),(1.27±0.98)h,AUC0–t were(14.4±5.81),(15.1±5.66)ng·h·mL-1,AUC0-∞ were(17.1±7.29),(16.7±6.77)ng·h·mL-1,in 200 μg groups respectively.The relative bioavailability was(97.2± 24.4)%.The data of the reference and tested drugs were not different as shown by F test.Conclusion The result shows that the two huperzine A tablets made in two different preparations are bioequivalent.Huperzine A sustain-release tablets clearly have the characteristic of slow releasing properties.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the bioavailability of the tested and reference huperzine A sustain-release tablets in healthy male volunteers.Methods According to the four-crossing design,each volunteer was orally given huperzine A sustain-release tablets or huperzine A.The plasma concentrations were determined by LC-MS/MS.Pharmacokinetic parameters were obtained using DAS 2.0 program.Results The main pharmacokinetic parameters of huperzine A tablets test and reference were as follows: Cmax were(0.75±0.25),(1.57±0.44)ng·mL-1,Tmax were(5.77±3.60),(1.27±0.98)h,AUC0–t were(14.4±5.81),(15.1±5.66)ng·h·mL-1,AUC0-∞ were(17.1±7.29),(16.7±6.77)ng·h·mL-1,in 200 μg groups respectively.The relative bioavailability was(97.2± 24.4)%.The data of the reference and tested drugs were not different as shown by F test.Conclusion The result shows that the two huperzine A tablets made in two different preparations are bioequivalent.Huperzine A sustain-release tablets clearly have the characteristic of slow releasing properties.
Key concepts: Huperzine A, Bioequivalence, Volunteer, Bioavailability, Pharmacokinetics, Cmax, Pharmacology, Immediate release